Improving personalized cancer treatments using advanced statistical methods
Bayesian Methods for Complex Precision Biotherapy Trials in Oncology
['FUNDING_R01'] · UNIVERSITY OF TX MD ANDERSON CAN CTR · NIH-10894898
This study is looking at new ways to make cancer treatments more personalized by using advanced methods to match therapies to individual patients based on their unique health traits, which could lead to better results and fewer side effects.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TX MD ANDERSON CAN CTR (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-10894898 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative statistical methods to enhance the design of clinical trials for cancer treatments, particularly biotherapies. By utilizing advanced Bayesian approaches, the project aims to tailor treatment assignments based on individual patient characteristics, such as their unique biomarkers and disease profiles. This personalized approach seeks to improve the effectiveness of cancer therapies and better manage treatment-related side effects. Patients may benefit from more precise treatment options that align with their specific medical needs.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancer who are undergoing or considering biotherapy treatments.
Not a fit: Patients with non-cancerous conditions or those not receiving biotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized cancer treatments, improving patient outcomes.
How similar studies have performed: Other research has shown promising results using Bayesian methods in clinical trials, indicating potential for success in this novel approach.
Where this research is happening
HOUSTON, UNITED STATES
- UNIVERSITY OF TX MD ANDERSON CAN CTR — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: THALL, PETER F — UNIVERSITY OF TX MD ANDERSON CAN CTR
- Study coordinator: THALL, PETER F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acute Graft Versus Host Disease